valuation

SanDisk surged 4.2% after Melius Research initiated coverage with a buy rating and $1,350 price target, betting on AI-driven structural demand for high-bandwidth memory.

Investment manager Conestoga Capital sold $45.7M of SPS Commerce shares in Q1 2026, nearly exiting position as stock plunges 59.8% annually.

Reddit, Royal Caribbean, and Roku report earnings this week, each presenting distinct opportunities amid different market and operational conditions.

SpaceX's $1.75 trillion IPO valuation exceeds traditional metrics but may be justified by transformational growth potential across Starlink, Starship, and emerging space-based services.

SpaceX targets $75B IPO at $1.75-$2T valuation with June launch. SEC filing confirms timeline through post-IPO lockup expiration.

Investor Michael Burry closes Palantir position, opens Salesforce stake amid AI agent disruption concerns affecting SaaS sector valuations and competitive positioning.

Broadcom's 106% AI semiconductor growth and 2028 customer visibility outpace Microsoft's cloud expansion amid soaring capex demands, making the chipmaker the more attractive AI investment.

Palantir Technologies trades 30% below peaks despite 70% revenue growth and 43% margins, but 231x earnings valuation leaves no room for error.

Nvidia reaches record highs and $5 trillion market cap valuation at 24x forward earnings—near cheapest in a year—with historical patterns suggesting continued upside ahead.

Morningstar identifies Microsoft, Salesforce, and Alphabet as undervalued software plays at three-year pricing lows, despite AI disruption concerns.

Celsius stock has plummeted 65% from peaks despite strong fundamentals. High valuation and intense competition pose risks, though growth potential remains.

SpaceX eyes historic $1.75T IPO, largest ever. Analysts debate whether valuation compares to successful Meta/Arm IPOs or bubble-bound Alibaba/Rivian.

Intel's 2024 stock surge trails Nvidia's 73% revenue growth. Despite Intel's AI momentum, Nvidia's proven execution and superior margins make it the better long-term buy.

SpaceX targets 2026 IPO at $1-1.75T valuation, raising $50-75B with 30% retail allocation. Investors should expect capital reallocation to other Musk companies.

Cameco rallies 200% as nuclear power gains favor, but 22x price-to-sales valuation versus 9x historical average suggests risks ahead for new investors.

$PLTR faces political risk from founder Thiel's donations and CEO rhetoric, but government contracts provide stability. Valuation remains stretched at 82x sales.

Eli Lilly shows 43% revenue growth and 51% EPS growth, backed by weight-loss drug leadership and $7B cancer acquisition. Forward P/E of 40 remains below historical average.

Microsoft shares down 10% in 2026 amid $37.5B capex concerns, but Morningstar rates stock 38% undervalued with $600 fair value target.

AI stocks rally continues with Microsoft at 20% discount and Nvidia, Broadcom poised for potential doubling amid accelerating chip demand.

UnitedHealth rallied 30% on strong Q1 earnings and raised 2026 guidance, but current 19x forward earnings valuation may have priced in improvements. Medicare Advantage headwinds persist.